The I-GENE team is pleased to welcome you to the 7th issue of the I-GENE newsletter.
I am proud to say that the team realized some major achievements during the last months. We have optimized the chemistry of our nanoformulation in terms of stability and ability to spontaneously cross the membranes of human melanoma cells to edit them.
Moreover, the superiority of our approach lies in the ability to switch the
system on with light which increases the safety level of the technology and
acceptability for future clinical applications. Please, stay up to date on the
I-GENE project by reading this and next project newsletters!